CALB1 BIOMARKER IN THE TREATMENT OF DE-DIFFERENTIATED LIPOSARCOMA USING XPO1 INHIBITORS… Application WO-2022246065-A1 World Intellectual Property Organisation (WIPO) 24 Nov 2022